Medicared For All Logo

Matthew Dykhuizen in Crestview Hills, Kentucky

Home Kentucky Crestview Hills

Matthew Dykhuizen has Ophthalmology as his primary medical specialty. Their primary office is: 2865 Chancellor Dr in Crestview Hills, Kentucky. There are 3 additional office locations for Matthew Dykhuizen that can be viewed towards the end of their profile.

They're a part of the: Tri-state Centers For Sight Inc medical group which has around 26 members. You can call their office at 859-331-1058 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Massachusetts Medical School and graduated in 2009 (around 15 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Matthew John Dykhuizen Office Phone and Directions

Matthew Dykhuizen
Tri-state Centers For Sight Inc
2865 Chancellor Dr
Crestview Hills, Kentucky 41017
859-331-1058


Patient Ratings
Please rate your experience with Matthew Dykhuizen below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 859-331-1058


Enter a starting address:


Healthcare Info for Matthew Dykhuizen

Medical School: University Of Massachusetts Medical School
Graduation Year: 2009
The Primary Medical Specialty for Matthew Dykhuizen is listed as: Ophthalmology
Approximate Years of Experience: 15
PAC (PECOS ID)#: 1153568456
NPI #: 1609004308
NPI Created On: 07/01/2009
NPI Last Updated Listed as: 11/28/2018
Primary Taxonomy Code: 207W00000X
License Number:
35.128411
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Blue Cross Blue Shield
  • Ambetter
  • MOLINA HEALTHCARE OF OHIO
  • CareSource
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Not Assigned.


Services and Procedures include:

  1. Removal of recurring cataract in lens capsule using laser
  2. Injection of drug into eye
  3. Examination of cornea and iris using lens device and slit lamp
  4. Diagnostic imaging of retina
  5. Extended examination of eye with drawing of retina
  6. Extended examination of eye with drawing of optic nerve and surrounding area (macula)
  7. Imaging of blood vessels in back of eye using fluorescein dye
  8. Photography of the retina
  9. New patient office or other outpatient visit, typically 45 minutes
  10. New patient office or other outpatient visit, typically 60 minutes
  11. Established patient office or other outpatient visit, typically 15 minutes
  12. Established patient office or other outpatient, visit typically 25 minutes
  13. Established patient office or other outpatient, visit typically 40 minutes
  14. Chronic care management services at least 20 minutes per calendar month
  15. Injection, aflibercept, 1 mg
  16. Injection, brolucizumab-dbll, 1 mg
  17. Unclassified biologics
  18. Injection, dexamethasone, intravitreal implant, 0.1 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 799202381

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Chronic Non-infectious Posterior Segment Uveitis

Name of Drug #1: YUTIQ

Open Associated Drug #1: 71879-136-01


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792758673

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792758675

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792758677

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792758679

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07


Payments Total: $35

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809574901

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809574903

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809574905

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809574907

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809574909

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Additional Office Locations

1. Tri-state Centers For Sight Inc
8780 Us
Florence, KY 41042
Suite 42
Group Members: 26

Phone: 859-331-1058

Enter a starting address:


2. Tri-state Centers For Sight Inc
2055 Reading Rd
Cincinnati, OH 45202
Suite 330
Group Members: 26

Phone: 859-331-1058

Enter a starting address:


3. Tri-state Centers For Sight Inc
1060 Nimitzview Dr
Cincinnati, OH 45230
Suite 105
Group Members: 26

Phone: 859-331-1058

Enter a starting address:


Ophthalmology Professionals in Crestview Hills

2865 Chancellor Dr
Crestview-hills, KY
Tri-state Centers For Sight Inc

2865 Chancellor Dr
Crestview-hills, KY
Tri-state Centers For Sight Inc

500 Thomas More Pkwy
Crestview-hills, KY
Tri-state Centers For Sight Inc

2865 Chancellor Dr
Crestview-hills, KY
Tri-state Centers For Sight Inc

500 Thomas More Pkwy
Crestview-hills, KY
Tri-state Centers For Sight Inc

465 Centre View Blvd
Crestview-hills, KY

Providers in Tri-state Centers For Sight Inc

1.Syeda Ahmed Naqvi

2135 Dana Ave
Cincinnati Oh 45207-1313
Tri-state Centers For Sight Inc
Ophthalmology

2.Syeda Ahmed Naqvi

500 Thomas More Pkwy
Crestview Hills Ky 41017-3454
Tri-state Centers For Sight Inc
Ophthalmology

3.Syeda Ahmed Naqvi

7510 Us Route 42
Florence Ky 41042-1908
Tri-state Centers For Sight Inc
Ophthalmology

4.Mark Cepela Md

2865 Chancellor Dr
Crestview Hills Ky 41017-3931
Tri-state Centers For Sight Inc
Ophthalmology

5.Mark Cepela Md

8270 Pine Rd
Cincinnati Oh 45236-1900
Tri-state Centers For Sight Inc
Ophthalmology

6.Mark Cepela Md

7730 Montgomery Rd
Cincinnati Oh 45236-4284
Tri-state Centers For Sight Inc
Ophthalmology

View all 26 members of Tri-state Centers For Sight Inc medical group